INTS
INTS clinical trials: INTENSITY THERAPEUTICS, INC.
Every trial on ClinicalTrials.gov where INTENSITY THERAPEUTICS, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 2
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
INTS on the catalyst calendar · INTS registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Dec 2027Sponsor estimate | NCT06263231A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas...Intensity Therapeutics, Inc. · Sarcoma,Soft Tissue | INTSLead | Phase 3 | Recruiting | Locked | Locked | Locked |
| Feb 22, 2023Actual | NCT03058289A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6Intensity Therapeutics, Inc. · Breast Cancer | INTSLeadBMYCollaboratorMRKCollaborator | Phase 1/Phase 2 | Completed | Locked | Locked | Locked |
| Mar 1, 2022Sponsor estimate | NCT04781725INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast CancerOttawa Hospital Research Institute · Breast Cancer | INTSCollaborator | Phase 2 | Unknown status | Locked | Locked | Locked |
- Primary completion Dec 2027Sponsor estimatePhase 3NCT06263231A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas...Intensity Therapeutics, Inc. · Sarcoma,Soft TissueRecruitingINTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 22, 2023ActualPhase 1/Phase 2NCT03058289A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6Intensity Therapeutics, Inc. · Breast Cancer
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 1, 2022Sponsor estimatePhase 2NCT04781725INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast CancerOttawa Hospital Research Institute · Breast CancerUnknown statusINTSCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner